Loading…
MICRO +4 REGULAR STRENGTH is a brand name for Zinc, supplied as a solution. The medicine, its uses, side effects and dosage are the same regardless of brand.
Used for: MICRO +4 REGULAR STRENGTH (4 Trace Elements Injection USP) is indicated for: • use as a supplement to intravenous solutions given for TPN. Its administration in TPN solutions helps to maintain plasma zinc, copper, manganese and chromium levels and to prevent depletion of endogenous stores of these elements and…
Verbatim from this product's HC label. Tap a section to expand.
2 Recommended Dose and Dosage Adjustment (Pediatrics) 05/2021 7 WARNINGS AND PRECAUTIONS, General 05/2021 TABLE OF CONTENTS Sections and Subsections that are not applicable at the time of authorization are not listed.
PART I:
HEALTH PROFESSIONAL INFORMATION .................................................................................. 4 1 INDICATIONS.......................................................................................................................................
1 PEDIATRICS ( ≤ 18 YEARS OF AGE) .................................................................................................. 2 GERIATRICS (≥ 65 YEARS OF AGE) ..................................................................................................
4 2 CONTRAINDICATIONS ....................................................................................................................... 4 4 DOSAGE AND ADMINISTRATION .....................................................................................................
1 DOSING CONSIDERATIONS ..................................................................................................................... 2 RECOMMENDED DOSE AND DOSAGE ADJUSTMENT .................................................................................
3 RECONSTITUTION .................................................................................................................................. 4 ADMINISTRATION ...................................................................................................................................
6 5 OVERDOSAGE .................................................................................................................................... 6
1 Adverse Reaction Overview MICRO +4 REGULAR STRENGTH (4 Trace Elements Injection USP) Page 9 of 17 Protected B / Protégé B No adverse reactions have been reported for the amount of zinc, copper, manganese, or chromium present in this product.
The amounts are small and toxicity symptoms are not likely to occur at the suggested dosage level.
, General 05/2021 TABLE OF CONTENTS Sections and Subsections that are not applicable at the time of authorization are not listed.
PART I:
HEALTH PROFESSIONAL INFORMATION .................................................................................. 4 1 INDICATIONS.......................................................................................................................................
1 PEDIATRICS ( ≤ 18 YEARS OF AGE) .................................................................................................. 2 GERIATRICS (≥ 65 YEARS OF AGE) ..................................................................................................
4 2 CONTRAINDICATIONS ....................................................................................................................... 4 4 DOSAGE AND ADMINISTRATION .....................................................................................................
1 DOSING CONSIDERATIONS ..................................................................................................................... 2 RECOMMENDED DOSE AND DOSAGE ADJUSTMENT .................................................................................
3 RECONSTITUTION .................................................................................................................................. 4 ADMINISTRATION ...................................................................................................................................
6 5 OVERDOSAGE .................................................................................................................................... 6 6 DOSAGE FORMS, STRENGTHS, COMPOSITION AND PACKAGING ............................................
7 7 WARNINGS AND PRECAUTIONS ...................................................................................................... 1 SPECIAL POPULATIONS ..................................................................................................................
• MICRO +4 REGULAR STRENGTH is contraindicated in patients who are hypersensitive to this drug or to any ingredient in the formulation, including any non-medicinal ingredient, or component of the container. For a complete listing, see 6 DOSAGE FORMS, STRENGTHS, COMPOSITION AND PACKAGING.
Not medical advice. Always read the patient information leaflet and follow your prescriber or pharmacist.
Other brands of Zinc in Canada.
Know a brand we are missing in Canada? Suggest a brand →
Brand names are compiled from public regulatory records for active-ingredient mapping only. Drugvu is not affiliated with any manufacturer. This is not medical advice.
1 PREGNANT WOMEN ................................................................................................................. 2 BREAST-FEEDING .....................................................................................................................
8 8 ADVERSE REACTIONS ...................................................................................................................... 1 ADVERSE REACTION OVERVIEW.............................................................................................................
8 9 DRUG INTERACTIONS ....................................................................................................................... 2 DRUG INTERACTIONS OVERVIEW ............................................................................................................
4 DRUG-DRUG INTERACTIONS................................................................................................................... 5 DRUG-FOOD INTERACTIONS ...................................................................................................................
6 DRUG-HERB INTERACTIONS ................................................................................................................... 7 DRUG-LABORATORY TEST INTERACTIONS ..............................................................................................
9 10 CLINICAL PHARMACOLOGY ............................................................................................................. 1 MECHANISM OF ACTION .......................................................................................................................
2 PHARMACODYNAMICS........................................................................................................................ 3 PHARMACOKINETICS..........................................................................................................................
11 11 STORAGE, STABILITY AND DISPOSAL ......................................................................................... 13 12 SPECIAL HANDLING INSTRUCTIONS ............................................................................................
13 PART II: SCIENTIFIC INFORMATION ....................................................................................................... 14 13 PHARMACEUTICAL INFORMATION ...............................................................................................
14 14 CLINICAL TRIALS ............................................................................................................................. 15 15 MICROBIOLOGY ...............................................................................................................................
15 MICRO +4 REGULAR STRENGTH (4 Trace Elements Injection USP) Page 3 of 17 Protected B / Protégé B 16 NON-CLINICAL TOXICOLOGY .........................................................................................................
15 PATIENT MEDICATION INFORMATION ................................................................................................... 16 MICRO +4 REGULAR STRENGTH (4 Trace Elements Injection USP) Page 4 of 17 Protected B / Protégé B PART I: HEALTH PROFESSIONAL INFORMATION 1 INDICATIONS MICRO +4 REGULAR STRENGTH (4 Trace Elements Injection USP) is indicated for: • use as a supplement to intravenous solutions given for TPN.
Its administration in TPN solutions helps to maintain plasma zinc, copper, manganese and chromium levels and to prevent depletion of endogenous stores of these elements and development of subsequent deficiency symptoms. 2 Recommended Dose and Dose Adjustments).
2 Geriatrics (≥ 65 years of age): MICRO +4 REGULAR STRENGTH is indicated for use in geriatric patients. No […]